XBKK
BCH
Market cap794mUSD
Nov 12, Last price
10.70THB
Name
Bangkok Chain Hospital PCL
Chart & performance
P/E
20.27
P/S
2.24
EPS
0.53
Div yield, %
3.46%
Shrs. gr., 5y
—
Rev. gr., 5y
5.94%
Revenues
11.91b
+1.01%
Net income
1.32b
+2.65%
CFO
2.63b
-1.65%
Dividend
Aug 27, 20260.35 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bangkok Chain Hospital Public Company Limited, along with its affiliated entities, operates an extensive network of healthcare facilities across Thailand. This network includes thirteen hospital branches and a dedicated polyclinic. The organization specializes in delivering advanced tertiary care and comprehensive diagnostic services. Beyond core medical provision, its business operations extend to offering consulting, operational oversight, asset administration, and procurement services, alongside property leasing activities. Additionally, the company is involved in the sale of health-focused beverages and provides medical analysis and research services. Established in 1984, its corporate headquarters are situated in Nonthaburi, Thailand.
Key people
Somporn Harnphanich
Executive Chairman of the Board, Deputy Chief Executive Officer · since 2023
Pornsuda Harnphanich
Chief Financial Officer, Executive Director · since 2020
Pornluck Harnphanich
Chief Operating Officer, Executive Director · since 2017
Kantaporn Harnphanich
Chief Marketing Officer, Executive Director · since 2015
Chalerm Harnphanich
Executive Chairman of the Board, Chief Executive Officer · since 2011
Voravee Kiattiniyomsak
Executive Director, Director - Accounting, Company Secretary · since 2016
Surapant Taweewikayakarn
Executive Director · since 2023
Phinij Harnphanich
Director · since 2017
Independent Director · since 2004
Independent Director · since 2004
Thawat Suntrajarn
Independent Director · since 2010
Independent Director · since 2004
IPO date
Nov 10, 2004
Employees
Domiciled in
TH
Incorporated in
TH
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||